Upgrade to SI Premium - Free Trial

Veeco Reports Third Quarter 2019 Financial Results

November 4, 2019 4:05 PM

Third Quarter 2019 Highlights:

PLAINVIEW, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third quarter ended September 30, 2019. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

U.S. Dollars in millions, except per share data
GAAP Results Q3 ’19 Q3 ’18
Revenue $109.0 $126.8
Net income (loss) $(11.8) $(9.0)
Diluted earnings (loss) per share $(0.25) $(0.19)


Non-GAAP Results Q3 ’19 Q3 ’18
Net income (loss) $2.6 $5.3
Operating income (loss) $4.0 $8.0
Diluted earnings (loss) per share $0.05 $0.11

“Veeco executed well in Q3 with revenue and EPS above the midpoint of our guided range. Our gross margin exceeded our guidance and the company returned to profitability on a non-GAAP basis,” commented William J. Miller, Ph.D., Chief Executive Officer. “We continue to experience demand for our EUV mask blank products and have shipped our second production system. This shipment, combined with revenue from multiple LSA systems, drove strong Front End Semiconductor sales. Additionally, shipments to our data storage customers remained solid as they continued to invest in technology and capacity.”

Guidance and Outlook

The following guidance is provided for Veeco’s fourth quarter 2019:

Please refer to the tables at the end of this press release for further details.

Conference Call Information

A conference call reviewing these results has been scheduled for today, November 4, 2019 starting at 5:00pm ET. To join the call, dial 1-888-394-8218 (toll free) or 1-646-828-8193 and use passcode 9227350. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET this evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Forward-looking Statements

To the extent that this news release discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the risks discussed in the Business Description and Management's Discussion and Analysis sections of Veeco's Annual Report on Form 10-K for the year ended December 31, 2018 and in our subsequent quarterly reports on Form 10-Q, current reports on Form 8-K and press releases. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

Veeco Contacts:
Investors:Media:
Anthony Bencivenga (516) 252-1438Kevin Long (516) 714-3978
[email protected] [email protected]


Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
Three months ended September 30, Nine months ended September 30,
2019 2018 2019 2018
Net sales$108,954 $126,757 $306,147 $443,110
Cost of sales 66,731 80,372 192,924 284,651
Gross profit 42,223 46,385 113,223 158,459
Operating expenses, net:
Research and development 22,639 23,544 68,901 72,793
Selling, general, and administrative 20,962 20,186 60,620 70,842
Amortization of intangible assets 4,312 4,183 12,773 28,102
Restructuring 1,828 2,057 3,874 7,669
Acquisition costs 249 2,906
Asset impairment 252,343
Other, net (153) 39 (232) 325
Total operating expenses, net 49,588 50,258 145,936 434,980
Operating income (loss) (7,365) (3,873) (32,713) (276,521)
Interest expense, net (4,330) (4,779) (12,742) (13,847)
Income (loss) before income taxes (11,695) (8,652) (45,455) (290,368)
Income tax expense (benefit) 72 301 407 (27,954)
Net income (loss)$(11,767) $(8,953) $(45,862) $(262,414)
Income (loss) per common share:
Basic$(0.25) $(0.19) $(0.97) $(5.55)
Diluted$(0.25) $(0.19) $(0.97) $(5.55)
Weighted average number of shares:
Basic 47,489 46,982 47,361 47,283
Diluted 47,489 46,982 47,361 47,283


Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands)
September 30, December 31,
2019 2018
(unaudited)
Assets
Current assets:
Cash and cash equivalents$135,259 $212,273
Restricted cash 687 809
Short-term investments 95,672 48,189
Accounts receivable, net 72,731 66,808
Contract assets 20,782 10,397
Inventories 135,190 156,311
Deferred cost of sales 2,198 3,072
Prepaid expenses and other current assets 23,762 22,221
Total current assets 486,281 520,080
Property, plant and equipment, net 77,801 80,284
Operating lease right-of-use assets 10,472
Intangible assets, net 72,376 85,149
Goodwill 184,302 184,302
Deferred income taxes 1,872 1,869
Other assets 29,172 29,132
Total assets$862,276 $900,816
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$34,702 $39,611
Accrued expenses and other current liabilities 40,641 46,450
Customer deposits and deferred revenue 66,031 72,736
Income taxes payable 663 1,256
Total current liabilities 142,037 160,053
Deferred income taxes 5,713 5,690
Long-term debt 296,810 287,392
Operating lease long-term liabilities 6,066
Other liabilities 9,180 9,906
Total liabilities 459,806 463,041
Total stockholders’ equity 402,470 437,775
Total liabilities and stockholders’ equity$862,276 $900,816


Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)
Non-GAAP Adjustments
Share-Based
Three months ended September 30, 2019 GAAP Compensation Amortization Other Non-GAAP
Net sales $108,954 $108,954
Gross profit 42,223 383 1,316 43,922
Gross margin 38.8 % 40.3%
Operating expenses 49,588 (3,400) (4,312) (1,920) 39,956
Operating income (loss) (7,365) 3,783 4,312 3,236 ^ 3,966
Net income (loss) (11,767) 3,783 4,312 6,302 ^ 2,630
Income (loss) per common share:
Basic $(0.25) $0.06
Diluted (0.25) 0.05
Weighted average number of shares:
Basic 47,489 47,495
Diluted 47,489 47,898
____________________________
^ - See table below for additional details.



Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)
Three months ended September 30, 2019
Restructuring 1,828
Release of inventory fair value step-up associated with the Ultratech purchase accounting 1,270
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 138
Subtotal 3,236
Non-cash interest expense 3,199
Non-GAAP tax adjustment * (133)
Total Other 6,302
____________________________
* - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)
Non-GAAP Adjustments
Share-based
Three months ended September 30, 2018 GAAP Compensation Amortization Other Non-GAAP
Net sales $126,757 $126,757
Gross profit 46,385 513 1,489 48,387
Gross margin 36.6 % 38.2%
Operating expenses 50,258 (2,766) (4,183) (2,892) 40,417
Operating income (loss) (3,873) 3,279 4,183 4,381 ^ 7,970
Net income (loss) (8,953) 3,279 4,183 6,813 ^ 5,322
Income (loss) per common share:
Basic $(0.19) $0.11
Diluted (0.19) 0.11
Weighted average number of shares:
Basic 46,982 46,984
Diluted 46,982 47,000
____________________________
^ - See table below for additional details.



Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)
Three months ended September 30, 2018
Restructuring 1,890
Acquisition related 249
Release of inventory fair value step-up associated with the Ultratech purchase accounting 1,411
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 236
Accelerated depreciation 595
Subtotal 4,381
Non-cash interest expense 2,968
Non-GAAP tax adjustment * (536)
Total Other 6,813
____________________________
* - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)
(in thousands)
(unaudited)
Three months ended Three months ended
September 30, 2019 September 30, 2018
GAAP Net income (loss)$ (11,767) $ (8,953)
Share-based compensation 3,783 3,279
Amortization 4,312 4,183
Restructuring 1,828 1,890
Acquisition related 249
Release of inventory fair value step-up associated with the Ultratech purchase accounting 1,270 1,411
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 138 236
Accelerated depreciation 595
Interest (income) expense, net 4,330 4,779
Income tax expense (benefit) 72 301
Non-GAAP Operating income (loss)$ 3,966 $ 7,970

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in millions, except per share amounts)
(unaudited)
Non-GAAP Adjustments
Guidance for the three months ending Share-based
December 31, 2019 GAAP Compensation Amortization Other Non-GAAP
Net sales $100 - $120 $100 - $120
Gross profit 38 - 48 1 39 - 49
Gross margin 39% - 41% 39% - 41%
Operating expenses ~$48 3 4 2 ~$39
Operating income (loss) (10) - 4 4 2 - 10
Net income (loss) $(15) - $(5) 4 4 5 $(2) - $8
Income (loss) per diluted common share $(0.32) - $(0.10) $(0.03) - $0.18
Weighted average number of shares 48 48 48 48


Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (Loss)
(in millions)
(unaudited)
Guidance for the three months ending December 31, 2019
GAAP Net income (loss) $(15) - $(5)
Share-based compensation 4 - 4
Amortization 4 - 4
Restructuring 2 - 2
Interest expense, net 4 - 4
Other 1 - 1
Non-GAAP Operating income (loss) $ - $10

Note: Amounts may not calculate precisely due to rounding.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Categories

Globe Newswire Press Releases

Next Articles